Zobrazeno 1 - 5
of 5
pro vyhledávání: '"CHIARA DEMOFONTI"'
Autor:
VERA CIRNIGLIARO, SILVIA PIETROSANTI, CHIARA DEMOFONTI, MARTINA DE ANGELI, DOROTEA GIOVENCO, LAURA CEDRONE, CECILIA SCIOMMARI, ALESSANDRA CAROSI, FRANCA PIETRASANTA, SARA RAMELLA, ROLANDO MARIA D’ANGELILLO
Publikováno v:
Cancer Diagn Progn
Background/Aim: The high sensitivity cardiac troponin T (Hs-cTnT) is a myocardial damage biomarker that could have a predictive value in patients who undergo radiotherapy for left sided breast cancer. The aim of this study was to evaluate the early e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60275a57be211a806b7f81e28fb3a74d
https://europepmc.org/articles/PMC10165385/
https://europepmc.org/articles/PMC10165385/
Autor:
Giulio Francolini, Beatrice Detti, Vanessa Di Cataldo, Saverio Caini, Anna Rita Alitto, Silvana Parisi, Chiara Demofonti, Alessio Bruni, Gianluca Ingrosso, Giorgia Timon, Andrea Allegra, Michele Aquilano, Lucia Pia Ciccone, Viola Salvestrini, Giulio Frosini, Cecilia Cerbai, Isacco Desideri, Icro Meattini, Monica Mangoni, Lorenzo Livi
Publikováno v:
Journal of Clinical Oncology. 40:100-100
100 Background: ARTO (NCT03449719) is a multicentre, randomized trial started in January 2019 and currently running in 16 Italian centres, testing the benefit of adding stereotactic body radiation therapy (SBRT) to Abiraterone Acetate (AA) in oligome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f46e9a9cbe291bbabd193a15b2a05eb2
https://doi.org/10.1200/jco.2022.40.6_suppl.100
https://doi.org/10.1200/jco.2022.40.6_suppl.100
Autor:
Riccardo Santoni, Emanuele Alì, Cynthia Aristei, Chiara Demofonti, Marta Bottero, Gianluca Ingrosso, Andrea Lancia
Magnetic resonance imaging (MRI) has been proposed as a staging tool for bladder cancer (BC), but its use has been limited by its high costs and limited availability. Microultrasound (mUS) is a novel technology capable of providing high-resolution im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1fc47874f6ec9e9288ed743e189474
https://europepmc.org/articles/PMC6989852/
https://europepmc.org/articles/PMC6989852/
Autor:
Martina Parisi, Marco Occhiuto, Salvatore Minisola, Jessica Pepe, Federica Biamonte, Valeria Baffa, Piergianni Biondi, Chiara Demofonti, Cristiana Cipriani
Publikováno v:
Clinical Cases in Mineral and Bone Metabolism. 14:207
Vitamin D supplementation represents an important topic in the field of metabolic bone disease. Calcidiol, the 25-hydroxy-vitamin D [25(OH)D], is the form of vitamin D most recently introduced in clinical practice. Advantages of the use of calcidiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9949d29d55bf70d9371376bc847c17ce
https://doi.org/10.11138/ccmbm/2017.14.1.207
https://doi.org/10.11138/ccmbm/2017.14.1.207
Autor:
Biondi, Piergianni1, Pepe, Jessica1, Biamonte, Federica1, Occhiuto, Marco1, Parisi, Martina1, Demofonti, Chiara1, Baffa, Valeria1, Minisola, Salvatore1, Cipriani, Cristiana1 cristiana.cipriani@gmail.com
Publikováno v:
Clinical Cases in Mineral & Bone Metabolism. May-Aug2017, Vol. 14 Issue 2, p207-208. 2p.